info@glycoselect.com

Blog

Use of Recombinant Prokaryotic Lectins (RPLs) for Coronavirus Research

Image of a coronavirus and its spikes

April 2020

RPLs for high-throughput analysis of biopharmaceuticals

December 2019

Glycosylation & Glycans

September 2019

Image of a coronavirus and its spikes

April 2020

Use of Recombinant Prokaryotic Lectins (RPLs) for Coronavirus Research

December 2019

RPLs for high-throughput analysis of biopharmaceuticals

September 2019

Glycosylation & Glycans

GlycoSeLect News Stories

US Biological to bring GlycoSeLect RPL lectins to life science researchers

GlycoSeLect announces opening of new laboratory facility and start of Series A fund raising round

Development of ink-printed RPL technology by Marie Skłodowska-Curie Career FIT Fellow at the University of Limerick

GlycoSeLect announces GLYcoDiag as a new distributor of its RPL recombinant lectin products

JSR Life Sciences and GlycoSeLect Enter Licensing and Joint Development Agreement

CPI Supports GlycoSeLect to Develop High Throughput Glycan Analysis Platform for Biotherapeutics